Companies Dominating the Vitamin K2 Landscape
- Kappa Bioscience Group
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Gnosis by Lesaffre
- Koninklijke DSM N.V
- Pfizer Inc.
- Viridis BioPharma Pvt. Ltd.
- DuPont de Nemours, Inc.
- Seebio Biotech (Shanghai) Co., Ltd.
- GeneFerm Biotechnology Co., Ltd.
- Kyowa Hakka Bio Co., Ltd.
- International Flavors & Fragrances Inc.
The competitive landscape of the Vitamin K2 market is rapidly evolving as established key players and new entrants are investing in launching quality supplements. Key players in the market are focused on developing new technologies and products catering to the stringent regulatory norms and consumer demand. These key players are adopting several strategies such as mergers and acquisitions, joint ventures, partnerships, and novel product launches to enhance their product base and strengthen their market position. Here are some key players operating in the global market:
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
2025 Vitamin K2 Market is estimated at USD 850.67 million.
The global vitamin K2 market size exceeded USD 705.6 million in 2024 and is poised to expand at a CAGR of more than 25.7%, crossing USD 13.8 billion by 2037.
North America is likely to command the top industry share, impelled by increasing consumer focus on health and rising osteoporosis cases.
The major players in the market include Kappa Bioscience Group, Gnosis by Lesaffre, Koninklijke DSM N.V, Pfizer Inc., Viridis BioPharma Pvt. Ltd., DuPont de Nemours, Inc., Seebio Biotech (Shanghai) Co., Ltd., GeneFerm Biotechnology Co., Ltd., Kyowa Hakka Bio Co., Ltd., International Flavors & Fragrances Inc.
